Ion Exchange profit margins shrink as Roha plant costs bite
EBITDA margins fell to 2.31% despite a 3% revenue rise, as new manufacturing lines came online and West Asia operations remained under pressure.
— 1 earlier story on Ion Exchange (India) Ltd. →What's new
- Q4 consolidated operating income rose 3% year-on-year to ₹8,633 million, but EBITDA margins fell to 2.31%.
- The compression was driven by costs at the new Roha facility and disruption from the West Asia crisis.
- The year-end engineering order book stood at ₹26,433 million, with order intake up 40% over the prior year.
Why this matters
The margin story is the negative. Revenue growth is being consumed by the cost base of a new plant that is still ramping up and a geopolitical conflict that is hitting dispatches. The 40% jump in order intake is a positive signal for future revenue, but the near-term profitability is being sacrificed to build that pipeline.
What we're watching
- How quickly Roha plant utilization improves and margins normalize.
- The timeline for resolving West Asia crisis-related disruptions to dispatches.
- Conversion of the ₹26,433 million order book into revenue and profit.
The full read
Ion Exchange's Q4 results tell a story of investment ahead of return. Revenue grew 3% year-on-year to ₹8,633 million, but EBITDA margins slid to 2.31%. The cause is clear: the new Roha plant is online and certified, but its costs are hitting the P&L now, while the export boost is still pending. The West Asia crisis is adding to the squeeze, disrupting both dispatches and input costs. On the strategic front, the commissioning of Roha and the MANN+HUMMEL technology transfer are medium-term positives. The strongest forward indicator is the order book: ₹26,433 million at year-end, with intake up 40%. The challenge is converting that book into revenue without repeating the current margin compression. For now, the company is spending to grow.
Questions answered
- Why did EBITDA margins fall even as revenue grew?
- The company cited costs associated with its new Roha manufacturing facility in Maharashtra and the ongoing impact of the West Asia crisis on operations and input costs. Both factors compressed profitability during the quarter.
- What is the significance of the Roha plant?
- All manufacturing lines at Roha are now complete and certified by the Water Quality Association. Management expects this to boost export sales, but the near-term effect is a margin headwind as the facility ramps up.
- How strong is the company's forward order book?
- The engineering order book stood at ₹26,433 million at year-end, supported by a 40% increase in order intake over the previous financial year. This provides a solid revenue pipeline for the medium term.
- What is the status of the MANN+HUMMEL partnership?
- Ion Exchange signed a technology transfer agreement with MANN+HUMMEL for ultra-filtration membranes. This partnership is intended to expand the company's capabilities in water treatment technology.
- What is the impact of the West Asia crisis?
- The crisis is affecting both dispatches to the region and input costs for the company. It remains a key operational headwind contributing to the margin compression seen in the quarter.
Story so far
All notes on IONEXCHANG →- 5 Jun 2026 · 5:25 PM IST Ion Exchange profit margins shrink as Roha plant costs bite
- 10d ago Ion Exchange profit drops 35% as margins buckle under costs